Last A$5.06 AUD
Change Today -0.14 / -2.69%
Volume 1.6M
ALQ On Other Exchanges
As of 12:10 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

als ltd (ALQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/8/14 - A$9.30
52 Week Low
11/21/14 - A$4.33
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ALS LTD (ALQ)

Related News

No related news articles were found.

als ltd (ALQ) Related Businessweek News

No Related Businessweek News Found

als ltd (ALQ) Details

ALS Limited, together with its subsidiaries, provides analytical and testing services. The company’s ALS Minerals segment provides testing services for mining industry in the service areas of geochemistry, metallurgy, mine site services, and inspection. Its services include exploration, feasibility, production, design, development, trading, and rehabilitation. This segment serves explorers, miners, and traders. Its ALS Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets. The company’s ALS Energy segment provides technical solutions and products to the coal, and oil and gas industries. It offers services and tools covering solids, liquids, and gas hydrocarbon markets. This segment also offers field and laboratory services, exploration, resource characterization, production enhancement, quality management, and trade-related services. Its ALS Industrial segment offers diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. This segment serves asset owners, operators, constructors, and equipment manufacturers in the power, petrochemical, mining, minerals processing, water, infrastructure, and transportation industries. The company’s Reward Distribution segment distributes non-food consumables to the healthcare, building services, hospitality, and leisure industries. ALS Limited operates in approximately 60 countries, primarily in Africa, Asia, Australia, Europe, and the Americas. The company was formerly known as Campbell Brothers Limited and changed its name to ALS Limited in August 2012. ALS Limited was founded in 1863 and is headquartered in Brisbane, Australia.

Founded in 1863

als ltd (ALQ) Top Compensated Officers

Chief Executive Officer, Managing Director, E...
Total Annual Compensation: A$1.8M
Chief Financial Officer
Total Annual Compensation: A$476.8K
Group General Manager of Life Sciences Divisi...
Total Annual Compensation: A$740.5K
Group General Manager of Minerals Division
Total Annual Compensation: A$716.0K
Group General Manager of Energy Division
Total Annual Compensation: A$682.5K
Compensation as of Fiscal Year 2014.

als ltd (ALQ) Key Developments

ALS Limited Reports Unaudited Earnings Results for the Third Quarter Ended December 2014

ALS Limited on November 24, 2014 provided commentary that it expected underlying net profit after tax for the December 2014 quarter to be approximately $40 million, slightly ahead of both the first and second quarters of the current financial year ending March 2015. Directors now advise that the unaudited December 2014 quarter's underlying net profit after tax was $46 million, 15% ahead of the forecast result. The result is an increase on both the First Quarter ($30 million) and Second Quarter ($38 million) of the current financial year, and in line with the third quarter of the previous financial year on a like for like basis. The better than forecast result was struck on stronger than expected geochemical sample flows and the benefits of cost reduction initiatives across all divisions. Total Group revenue for the December quarter was $376 million compared to $373 million in the December 2013 quarter; excluding Reward Distribution which was divested in October 2014. The Geochemistry Business had its strongest quarter for the calendar year with revenue of $75 million (EBIT margin 29.1%) compared to the September 14 quarter revenue $70 million (EBIT margin 22.7%), June 14 quarter revenue $63 million (EBIT margin 20.0%), and December 13 quarter revenue $78 million (EBIT margin 26.8%). The Life Sciences Division had a strong quarter with revenue of $148 million compared to the December 13 quarter of $141 million and more importantly an EBIT margin of 20.6% compared to 18.8% pcp. The Industrial Division saw revenue in the December quarter slightly down on the December quarter last year but the EBIT margin improved to 14.4% compared to 13.0% pcp to produce a slightly better EBIT result. The Energy Division generated quarterly revenue of $82 million at an EBIT margin of 15.0% compared to revenue of $84 million and a 19.7% margin pcp.

ALS Limited Reports Consolidated Unaudited Earnings Results for the Half Year Ended September 30, 2014; Provides Earnings Guidance for the Third Quarter Ending December 2014

ALS Limited reported consolidated unaudited earnings results for the half year ended September 30, 2014. For the period, the company reported revenue of AUD 710.3 million compared to AUD 684.6 million a year ago. Profit before financing costs and income tax was AUD 100.8 million against AUD 142.4 million a year ago. Profit before income tax was AUD 84.2 million against AUD 132.7 million a year ago. Profit from continuing operations was AUD 60.2 million or 15.0 cents per basic and diluted share against AUD 97.7 million or 26.9 cents per basic and diluted share a year ago. Profit attributable to equity holders of the company was AUD 58.4 million or 14.7 cents per basic and diluted share against AUD 97.7 million or 27.1 cents per basic and diluted share a year ago. Net cash from operating activities was AUD 87.2 million against AUD 100.5 million a year `ago. Payments for property, plant and equipment was 37.5 million against AUD 39.4 million a year ago. Net tangible assets per ordinary share were 2.41 cents against 6.86 cents a year ago. Underlying revenue was AUD 769.1 million against AUD 744.7 million a year ago. Underlying EBITDA was AUD 151.4 million compared to AUD 183.0 million a year ago. Underlying EBIT was AUD 110.3 million compared to AUD 148.1 million a year ago. Underlying NPAT was AUD 67.7 million or 17.1 cents per basic and diluted share compared to AUD 100.8 million or 27.9 cents per basic and diluted share a year ago. The company expects after tax group net profit for the December 2014 quarter is expected to be approximately AUD 40 million. This represents an improvement in performance over each of the first two quarters (AUD 30.0 million and AUD 37.7 million) of the current financial year.

ALS LimitedDeclares Interim Dividend for the Six Months Ended September 30, 2014 Payable on December 19, 2014

ALS Limited declared a partly franked (10%) interim dividend for the six months ended September 30, 2014 of 11 cents per share payable on all ordinary shares compared to 19 cents per share, partly franked to 50% a year ago. It will be paid on December 19, 2014 on all shares registered in the company's register at the close of business on December 4, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALQ:AU A$5.06 AUD -0.14

ALQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bureau Veritas SA €18.90 EUR +0.17
Core Laboratories NV $99.84 USD -6.64
Eurofins Scientific SE €230.20 EUR -2.40
Intertek Group PLC 2,291 GBp +3.00
Mistras Group Inc $20.47 USD -0.54
View Industry Companies

Industry Analysis


Industry Average

Valuation ALQ Industry Range
Price/Earnings 16.0x
Price/Sales 1.2x
Price/Book 1.3x
Price/Cash Flow 9.1x
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at